Fluidigm Posts 21 Percent Q4 Sales Growth | GenomeWeb

NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Tuesday that its fourth-quarter revenues increased 21 percent year over year, as the firm easily beat the consensus Wall Street estimates on the top and bottom line.

The South San Francisco, Calif.-based microfluidic systems developer had total revenues of $15.7 million for the three months ended Dec. 31, compared to $13 million for the fourth quarter of 2011. Analysts, on average, had expected revenues of $14.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.